Connect Biopharma Holdings (CNTB) Other financing activities (2024 - 2026)

Connect Biopharma Holdings has disclosed Other financing activities across 3 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Other financing activities rose 986.71% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $20.9 million (up 8750.0% YoY), while the FY2025 annual figure was $875000.0, up 351.03% from the prior year.
• Other financing activities came in at $1.6 million for Q2 2026 at Connect Biopharma Holdings, down from $18.6 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $18.6 million in Q1 2026 to a low of $92000.0 in Q3 2025.
• Average Other financing activities over 3 years is $3.0 million, with a median of $143000.0 recorded in 2025.
• Year-over-year, Other financing activities surged 41.58% in 2025 and soared 986.71% in 2026.
• Over 3 years, Other financing activities stood at $93000.0 in 2024, then surged by 588.17% to $640000.0 in 2025, then soared by 142.81% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $1.6 million in Q2 2026, $18.6 million in Q1 2026, and $640000.0 in Q4 2025.